Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"In vivo" and "in vitro": tests in the diagnosis of trichophyton allergy.

European annals of allergy and clinical immunology·2008
Same author

Drug allergy and asthma.

European annals of allergy and clinical immunology·2007
Same author

The asthma rhinitis link.

European annals of allergy and clinical immunology·2007
Same author

Drug allergy and pollinosis. A short report.

European annals of allergy and clinical immunology·2007
Same author

"In vivo" and "in vitro" tests in the diagnosis of Beta-lactams allergy.

European annals of allergy and clinical immunology·2007
Same author

Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study.

Allergologia et immunopathologia·2006

Related Experiment Video

Updated: Jul 14, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Alpha-1-antitrypsin deficiency asthma and allergy.

A G Palma-Carlos1, M L Palma-Carlos

  • 1Clinical Allergy Immunology Center-CAIC, Lisbon, Portugal.

European Annals of Allergy and Clinical Immunology
|May 26, 2007
PubMed
Summary

Alpha-1-antitrypsin deficiency (AATD) impacts biochemistry and genetics. This review covers AATD phenotypes in Europe, presenting cases and discussing AATD

Area of Science:

  • Biochemistry
  • Genetics
  • Pathology

Background:

  • Review of alpha-1-antitrypsin deficiency (AATD) biochemistry, genetics, and pathology.
  • Discussion of AATD phenotypes (M, SZ) geographical distribution in Europe.

Observation:

  • Presentation of two AATD cases: one ZZ homozygote (non-smoker, no respiratory issues) and one SZ heterozygote (heavy smoker, severe COPD with asthma-like reversibility).

Findings:

  • Highlights the variable clinical presentation of AATD based on genotype and environmental factors (smoking).
  • Suggests a potential link between alpha-1-antitrypsin levels and asthma development or severity.

Implications:

  • Informs understanding of AATD's complex relationship with respiratory diseases like COPD and asthma.

More Related Videos

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
10:25

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

Related Experiment Videos

Last Updated: Jul 14, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
10:25

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

  • Suggests potential avenues for AATD treatment and prevention strategies.